National Medical Care Company (TADAWUL:4005)
101.00
-3.00 (-2.88%)
Jun 11, 2026, 3:19 PM AST
TADAWUL:4005 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, TADAWUL:4005 stock has a consensus rating of "Buy" and an average price target of SAR 155.33. The average 1-year stock price forecast is 53.79% higher than the current stock price, while the lowest is SAR 113.00 (+11.88%) and the highest is SAR 225.00 (+122.77%).
Price Target: SAR 155.33 (+53.79%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4005 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 6 | 6 |
Financial Forecast
Revenue This Year
1.72B
from 1.60B
Increased by 7.52%
Revenue Next Year
1.84B
from 1.72B
Increased by 6.95%
EPS This Year
6.62
from 7.13
Decreased by -7.15%
EPS Next Year
7.82
from 6.62
Increased by 18.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8B | ||
| Avg | 1.7B | ||
| Low | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.7% | ||
| Avg | 7.5% | ||
| Low | 5.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 6.62 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -7.1% | ||
| Low | - |